Literature DB >> 21099433

Practice patterns of cardiologists, general practitioners, and internists for managing supraventricular tachycardias in Greece.

Vassilios P Vassilikos1, Lilian Mantziari, Christos A Goudis, Stelios Paraskevaidis, Georgios Dakos, Georgios Stavropoulos, Georgios Giannoglou, Georgios Efthimiadis, Sotirios Mochlas, Georgios Parcharidis, Georgios Louridas, Ioannis H Styliadis.   

Abstract

OBJECTIVES: Supraventricular tachycardias (SVT) often lead to emergency room and primary care visits. Not only cardiologists, but also general practitioners (GPs) and internists are involved to an increasing extent in the acute and long-term management of SVT. We aimed to explore the differences between practice patterns of cardiologists and noncardiologists with regard to SVT management in Greece.
METHODS: A cross-sectional questionnaire survey was conducted among 250 cardiologists and 250 GPs/internists from various areas across Greece.
RESULTS: A response rate of 61.8% was obtained. Vagal maneuvers were the initial therapeutic approach for SVT termination; however, 22% of noncardiologists would rather start with an antiarrhythmic drug. Adenosine was the most popular drug for SVT termination, but the GPs/internists would use it less often than the cardiologists (67 vs. 86%, P<0.001). The GPs/internists would keep the patient for at least 24 h or more after SVT termination, while 48% of the cardiologists would discharge the patient within the first 3 h. Noncardiologists would more often suggest a 24-h Holter recording than the cardiologists (73 vs. 55%, P<0.005). With regard to the long-term management of SVT, the GPs/internists would prescribe antiarrhythmic drugs earlier than the cardiologists, and seem to be less familiar with the indications for the electrophysiological testing and ablation.
CONCLUSION: Significant differences in practice patterns exist in Greece with regard to SVT management between cardiologists and noncardiologists. The GPs/internists seem to rely more on antiarrhythmic drugs and tend to underestimate the role of ablation therapy for the long-term management of SVT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21099433     DOI: 10.1097/MEJ.0b013e328341ee61

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  2 in total

1.  Electrophysiological predictors of propafenone efficacy in prevention of atrioventricular nodal re-entrant and atrioventricular re-entrant tachycardia.

Authors:  Hrvoje Pintarić; Ivan Zeljković; Zdravko Babić; Mislav Vrsalović; Nikola Pavlović; Hrvojka Bosnjak; Dubravko Petrac
Journal:  Croat Med J       Date:  2012-12       Impact factor: 1.351

2.  Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire.

Authors:  Philippe-Richard Domeyer; Smaragda Ch Giannakidou; Panagiota Kyriakou; Vasiliki Katsari; Antonios P Antoniadis; Ioannis K Lagos; Nikolaos Fragakis; Agoritsa Varaklioti; Vassilios P Vassilikos
Journal:  Biomed Res Int       Date:  2018-10-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.